Table 1

Clinical and surgical characteristics of laparoscopic bariatric surgery patients in the TAP block and no-TAP groups

Roux-en-Y gastric bypassSleeve gastrectomy
TAP blockNo-TAPP value*†TAP BlockNo-TAPP value*†
Sample size, n9450172193
Sociodemographic characteristics
 Mean age (SD) in years45.2 (11.3)43.7 (11.5)0.4544.9 (11.2)44.1 (10.7)0.45
 Female gender n(%)79 (84)37 (74)0.18135 (79)160 (83)0.29
 Race n(%)
  White60 (64)30 (60)0.6669 (40)70 (36)0.41
  African American33 (35)20 (40)102 (59)123 (64)
  Asian1 (1)0 (0)1 (1)0 (0)
 Ethnicity n (%)0.43
 Hispanic28 (30)11 (22)28 (16)26 (14)0.46
 Comorbidities
 Current smoker n (%)24 (25)19 (38)0.1341 (24)52 (27)0.55
 Obstructive sleep apnea n (%)36 (38)11 (22)0.0662 (36)37 (19)<0.01
 Diabetes n (%)28 (30)21 (42)0.1540 (23)46 (24)0.90
 Preoperative opioid use n (%)8 (9)5 (10)0.7715 (9)16 (8)0.88
 History of chronic pain n (%)20 (21)17 (34)0.1135 (20)37 (19)0.79
 Depression n (%)4 (4)4 (8)0.459 (3)13 (7)0.66
 Anxiety n (%)12 (13)9 (18)0.4521 (12)20 (10)0.62
Surgical characteristics
 Duration of surgery (SD) in minutes113 (23)125 (28)<0.0174 (29)83 (36)<0.01
 ASA classification n(%)
  II37 (39)13 (26)0.1471 (41)65 (34)0.32
  III57 (61)37 (74)99 (58)126 (65)
  IV2 (1)2 (1)
 Mean BMI (SD) in kg/m2 39.9 (8.4)38.5 (9.2)0.3939.8 (6.9)38.3 (6.8)0.04
 Intraoperative remifentanil n(%)72 (77)31 (62)0.08109 (63)102 (53)0.05
 Median (IQR) remifentanil dose in µg1096 (729–1852)2100 (1348–2592)<0.01665 (437–1079)1223 (780–1674)0.04
  • *P value compares TAP to no-TAP group.

  • †Group t-test used to compare means, Wilcoxon ranked sum test used to compare medians and χ² test used to compare proportions.

  • ASA, American Society of Anesthesiologists; BMI, body mass index; IQR, interquartile range (first to third quartile); TAP, transversus abdominis plane block.